Taiwan FDA registration 9de758cf7b69c35d5e271b0e466ece9a
"Aikuailu" Respiratory Fusion Cell Virus Rapid Test Reagent (Unsterilized)
TW: "艾快露" 呼吸道融合細胞病毒快速檢驗試劑 (未滅菌)
Taiwan·Risk Class 1·ACRO BIOTECH INC.·Registered Sep 10, 2016 – Sep 10, 2026ActiveRegistration details
- Analysis ID
- 9de758cf7b69c35d5e271b0e466ece9a
- Customs Code
- DHA09401699109
Company information
- Manufacturer
- ACRO BIOTECH INC.
- Manufacturer Country
- United States
- Authorized Representative
- Grand Marquis IVD CO., LTD.
Product details
- Intended Use
- Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3480 呼吸道融合細胞病毒血清試劑
- Import Information
- Input;; QMS/QSD
Dates and status
- Registration Date
- Sep 10, 2016
- Expiry Date
- Sep 10, 2026
About this record
Access comprehensive regulatory information for "Aikuailu" Respiratory Fusion Cell Virus Rapid Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 9de758cf7b69c35d5e271b0e466ece9a and manufactured by ACRO BIOTECH INC.. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices